We also verified that there was a negative correlation between miR-200a-3p and BACE1 in the blood of AD patients and that the imposed upregulation of miR-200a-3p significantly downregulated the expression of BACE1 at the protein level. This evidence concerns the gene BACE1 and Alzheimer disease.